Up-Regulation of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase (IDO) with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia

#1436

Introduction: Data from a considerable number of malignancies demonstrate that depletion of the essential amino acid tryptophan via induction of the immuno-regulatory enzyme Indoleamine-2,3-dioxygenase (IDO) serves as an important tumour escape strategy and is of prognostical importance.

Aim(s): Here we investigate the activity of IDO as well as serum levels of tryptophan and respective downstream catabolites in a large cohort of NEN patients.

Materials and methods: 142 consecutive Caucasian patients (62 male, aged 60.3±11.9 years) with histologically confirmed NEN were systematically analysed in a retrospective blinded endpoint analysis. Patients were followed up for a mean period of about 3.9±1.9 years and clinical outcome, levels of established biomarkers, and tryptophan degradation markers (assessed using tandem mass spectrometry) including estimated IDO-activity were recorded.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: unknown u

Authors: Pschowski R, Pape U, Fusch G, Jann H, Maasberg S,

Keywords: IDO-1, inflammation, tryptophan catabolites, predictor, biomarker,

To read the full abstract, please log into your ENETS Member account.